KBI Global Investors’s AbbVie ABBV Stock Holding History

KBI Global Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$18.8M	Buy	+303,192	New	+$18.5M	0.5%	71

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

KBI Global Investors's ABBV Position: Q2 2016 in Review

KBI Global Investors opened a new position in AbbVie (ABBV) in Q2 2016: 303,192 shares worth $18.8M. The stake represents 0.5% of the portfolio and ranks #71 among its holdings.

1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

KBI Global Investors held 303,192 shares of AbbVie worth $18.8M as of Q2 2016.
AbbVie was a new KBI Global Investors position in Q2 2016.
AbbVie made up 0.5% of KBI Global Investors's portfolio in Q2 2016, its #71 holding.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on KBI Global Investors's 13F filing for Q2 2016, filed 3 Aug 2016.